[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB201720189D0 - Dopamine-B-hydroxylase inhibitors - Google Patents

Dopamine-B-hydroxylase inhibitors

Info

Publication number
GB201720189D0
GB201720189D0 GBGB1720189.8A GB201720189A GB201720189D0 GB 201720189 D0 GB201720189 D0 GB 201720189D0 GB 201720189 A GB201720189 A GB 201720189A GB 201720189 D0 GB201720189 D0 GB 201720189D0
Authority
GB
United Kingdom
Prior art keywords
dopamine
hydroxylase inhibitors
hydroxylase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1720189.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bial Portela and Cia SA
Original Assignee
Bial Portela and Cia SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bial Portela and Cia SA filed Critical Bial Portela and Cia SA
Priority to GBGB1720189.8A priority Critical patent/GB201720189D0/en
Publication of GB201720189D0 publication Critical patent/GB201720189D0/en
Priority to MX2020005864A priority patent/MX2020005864A/en
Priority to BR112020010216-4A priority patent/BR112020010216A2/en
Priority to AU2018379646A priority patent/AU2018379646A1/en
Priority to PCT/PT2018/050043 priority patent/WO2019112457A1/en
Priority to RU2020121820A priority patent/RU2020121820A/en
Priority to JP2020530502A priority patent/JP7167155B2/en
Priority to EP18833340.5A priority patent/EP3720856A1/en
Priority to CN201880080871.5A priority patent/CN111479812A/en
Priority to SG11202004231YA priority patent/SG11202004231YA/en
Priority to TW107143059A priority patent/TW201925193A/en
Priority to CA3082337A priority patent/CA3082337A1/en
Priority to KR1020207019157A priority patent/KR20200096584A/en
Priority to US16/769,045 priority patent/US11434242B2/en
Priority to ARP180103525A priority patent/AR114150A1/en
Priority to IL274550A priority patent/IL274550B2/en
Priority to CL2020001461A priority patent/CL2020001461A1/en
Priority to PH12020500542A priority patent/PH12020500542A1/en
Priority to US17/901,007 priority patent/US20230138795A1/en
Ceased legal-status Critical Current

Links

GBGB1720189.8A 2017-12-04 2017-12-04 Dopamine-B-hydroxylase inhibitors Ceased GB201720189D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GBGB1720189.8A GB201720189D0 (en) 2017-12-04 2017-12-04 Dopamine-B-hydroxylase inhibitors
US16/769,045 US11434242B2 (en) 2017-12-04 2018-11-30 Dopamine-b-hydroxylase inhibitors
CN201880080871.5A CN111479812A (en) 2017-12-04 2018-11-30 dopamine-B-hydroxylase inhibitors
TW107143059A TW201925193A (en) 2017-12-04 2018-11-30 Dopamine-[beta]-hydroxylase inhibitors
AU2018379646A AU2018379646A1 (en) 2017-12-04 2018-11-30 Dopamine-B-hydroxylase inhibitors
PCT/PT2018/050043 WO2019112457A1 (en) 2017-12-04 2018-11-30 Dopamine-β-hydroxylase inhibitors
RU2020121820A RU2020121820A (en) 2017-12-04 2018-11-30 DOPAMINE B-HYDROXYLASE INHIBITORS
JP2020530502A JP7167155B2 (en) 2017-12-04 2018-11-30 Dopamine-B-hydroxylase inhibitor
EP18833340.5A EP3720856A1 (en) 2017-12-04 2018-11-30 Dopamine-& x392;-hydroxylase inhibitors
MX2020005864A MX2020005864A (en) 2017-12-04 2018-11-30 Dopamine-î’-hydroxylase inhibitors.
SG11202004231YA SG11202004231YA (en) 2017-12-04 2018-11-30 Dopamine-β-hydroxylase inhibitors
BR112020010216-4A BR112020010216A2 (en) 2017-12-04 2018-11-30 dopamine ¿hydroxylase inhibitors
CA3082337A CA3082337A1 (en) 2017-12-04 2018-11-30 Dopamine-b-hydroxylase inhibitors
KR1020207019157A KR20200096584A (en) 2017-12-04 2018-11-30 Dopamine-B-hydroxylase inhibitor
ARP180103525A AR114150A1 (en) 2017-12-04 2018-12-03 DOPAMINE-b-HYDROXYLASE INHIBITORS
IL274550A IL274550B2 (en) 2017-12-04 2020-05-10 Dopamine-b-hydroxylase inhibitors
CL2020001461A CL2020001461A1 (en) 2017-12-04 2020-06-01 Dopamine-b-hydroxylase inhibitors.
PH12020500542A PH12020500542A1 (en) 2017-12-04 2020-06-02 Dopamine-b-hydroxylase inhibitors
US17/901,007 US20230138795A1 (en) 2017-12-04 2022-09-01 Dopamine-b-hydroxylase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1720189.8A GB201720189D0 (en) 2017-12-04 2017-12-04 Dopamine-B-hydroxylase inhibitors

Publications (1)

Publication Number Publication Date
GB201720189D0 true GB201720189D0 (en) 2018-01-17

Family

ID=60950212

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1720189.8A Ceased GB201720189D0 (en) 2017-12-04 2017-12-04 Dopamine-B-hydroxylase inhibitors

Country Status (2)

Country Link
AR (1) AR114150A1 (en)
GB (1) GB201720189D0 (en)

Also Published As

Publication number Publication date
AR114150A1 (en) 2020-07-29

Similar Documents

Publication Publication Date Title
IL283639A (en) Kif18a inhibitors
IL287113A (en) Smyd inhibitors
IL269196A (en) Novel inhibitors
IL260217B (en) Lsd1 inhibitors
ZA202104029B (en) Rad51 inhibitors
IL248895A0 (en) Phosphatidylinositol -kinase inhibitors
IL265139B (en) Dopamine-b-hydroxylase inhibitors
ZA201907136B (en) Ip6k inhibitors
IL274523A (en) Immunoproteasome inhibitors
GB201501004D0 (en) Inhibitors
GB201612860D0 (en) Inhibitors
IL276013A (en) Pi4kiiibeta inhibitors
RS61811B1 (en) Immunoproteasome inhibitors
IL281514A (en) O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors
IL274550A (en) Dopamine-b-hydroxylase inhibitors
PL3710457T3 (en) Immunoproteasome inhibitors
GB201520949D0 (en) Inhibitors
EP3067422C0 (en) Ct-1 inhibitors
GB201721465D0 (en) Inhibitors
GB201720189D0 (en) Dopamine-B-hydroxylase inhibitors
GB201812462D0 (en) Inhibitors
GB201804439D0 (en) Dopamin-b-hydroxylase inhibitors
GB201418154D0 (en) Inhibitors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)